News

New Phase 3 trial results for a personalised mRNA treatment for people with high-risk melanoma are encouraging, offering hope for further progress…

5-a-side scores for Melanoma UK.   The first Barrie Maltby Memorial Cup has been hailed a success, bringing people together for a…

 As member of One Cancer Voice (the UK Coalition of over 70 Cancer Charities) Melanoma UK is  encouraging the support of the…

Melanoma UK appoints Rachel Wallace as new Chief Executive Officer. Melanoma UK has appointed Rachel Wallace as its new Chief Executive Officer,…

Ground breaking research at King’s On Wednesday 7th October Colin (our C.O.O.) visited King’s College London Labs at Guy’s Hospital to present…

Facing fears and fighting cancer with a Great White Shark challenge. After facing two cancer diagnoses, Luke Rogers from Staffordshire is turning…

A huge thank you to Ryan Mcevoy who ran the Robin Hood Half Marathon on Sunday 27th September, raising vital funds for…

The Department of Health and Social Care (DHSC) has announced the launch of a reformed National Cancer Board, which will scrutinise progress…

Melanoma UK announces Rachel Wallace as new Chief Executive Melanoma UK is delighted to announce the appointment of Rachel Wallace as its…

A personalised cancer treatment developed by Moderna and Merck has shown positive trial results in helping prevent high-risk melanoma from returning after…

Melanoma UK continues to support leading research projects. Our charity is delighted to announce two winners of our 2026 Grants Call. Following…

‘DETERMINE’ is Cancer Research UK’s national precision medicine trial for patients with rare and less common cancers.   This trial is looking…